Company
Headquarters: Mexico City, DF, Mexico
Employees: 2,076
CEO: Dr. Misael Uribe Esquivel
MX$4.39 Billion
MXN as of Jan. 1, 2024
US$258.5 Million
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Médica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. The company offers bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast cosmetic, stereotactic radio, hip arthroplasty, knee arthroscopy, shoulder arthroscopy, spine, lithiasis, radical prostatectomy, and prostate surgeries. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services. The company was incorporated in 1966 and is based in Mexico City, Mexico. Médica Sur, S.A.B. de C.V. is a subsidiary of Neuco, SA de CV.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Médica Sur, S.A.B. de C.V. has the following listings and related stock indices.
Stock: BMV: MEDICAB wb_incandescent